906329-46-2Relevant academic research and scientific papers
CYCLOPROPYLAMINES AS LSD1 INHIBITORS
-
, (2015/09/22)
The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
CYCLOPROPYLAMINES AS LSD1 INHIBITORS
-
Paragraph 0489; 0490, (2015/09/22)
The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
CYCLOPROPYLAMINES AS LSD1 INHIBITORS
-
Paragraph 0456, (2015/09/22)
The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
CYCLOPROPYLAMINES AS LSD1 INHIBITORS
-
Paragraph 0341; 0342, (2015/09/22)
The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
INHIBITORS OF TRYPTASE
-
Page/Page column 160-161, (2008/06/13)
The present invention related to certain inhibitors of tryptase that are inhibitors of tryptase, pharmaceutical composition comprising these compounds and method of treating asthma, allergic rhinitis, and/or Chronic Obstructive Pulmonary Disease utilizing these compounds.
PIPERIDINE DERIVATIVES AS ANTAGONISTS OF THE CC CHEMOKINE RECEPTOR CCR1 AND THEIR USE AS ANTI-INFLAMMATORY AGENTS
-
Page/Page column 40, (2008/06/13)
Piperidine derivatives of the following formulae (I) and (II) and their pharmaceutically acceptable salts, which are functional antagonists of the CC chemokine receptor CCR1 and are thus useful as anti inflammatory agents, a pharmaceutical compositions co
